What is Verix?
Founded in 2004 and headquartered in Santa Clara, California, Verix specializes in delivering AI-driven analytic solutions tailored for Sales and Marketing teams. The company primarily serves the Pharma and Consumer Packaged Goods (CPG) industries, providing critical business intelligence to enhance decision-making and performance. Verix's focus on these data-intensive sectors highlights its capability to offer sophisticated, actionable insights through advanced analytics.
How much funding has Verix raised?
Verix has raised a total of $20.8M across 3 funding rounds:
Series B
$12.7M
Series A
$8M
Debt
$137K
Series B (2006): $12.7M with participation from Hillsven Capital, Gemini Israel Ventures, and Viola Group
Series A (2019): $8M, investors not publicly disclosed
Debt (2021): $137K supported by PPP
Key Investors in Verix
Gemini Israel Ventures
Gemini Investors is a private investment firm focused on the smaller end of the middle market, investing in established companies with experienced management teams and strong growth potential. The firm provides both equity and debt capital, engaging in minority ownership or control transactions across various sectors including Business Services, Consumer Products and Services, Healthcare, Later Stage Technology, Manufacturing & Distribution, and Waste & Recycling.
Viola Group
Viola Group is Israel's leading technology investment group, managing over $6 billion in assets. The firm supports Israeli entrepreneurs in building transformational technology companies through its multi-strategy investment approach. It operates several investment arms, including Viola Ventures, Viola Growth, Viola Credit, and Viola FinTech, catering to companies at various stages of development.
PPP
Public-Private Partnership
What's next for Verix?
With a history of significant capital infusions, Verix is well-positioned to further its innovation in AI-powered sales and marketing analytics. The recent major strategic investment likely fuels continued product development, market penetration, and potential expansion into new verticals or geographies. The company's established presence in the Pharma and CPG sectors, combined with its robust business intelligence platform, suggests a strategic focus on deepening its market share and enhancing its competitive edge through technological advancement and data-driven solutions.
See full Verix company page
